The Bcl-2 protein family significantly inhibits apoptosis, and FMN shows a dose-dependent inhibition of Bax/Bcl-2 and caspase-3/9 protein expressions in ovarian cancer cells, thereby exhibiting anti-proliferative, anti-migratory, and invasive effects. The gene discussed is BCL2; the disease is ovarian carcinoma.